Plasma proteins, metabolites, and platelet changes in extracorporeal CPR for cardiac arrest patients
Official title: Explore Plasma Biomarkers and Platelet Morphological Signatures for Predicting Prognosis in Patients With Extracorporeal CardioPulmonary Resuscitation (ECPR) Using Multi-omics and Platelet Morphology Analysis
Run by Central China Fuwai Hospital of Zhengzhou University · NCT07113769 · Data updated 2026-11-12
This project will test whether patterns in blood proteins, small molecules, and platelet shape changes can help identify which adults with cardiac arrest might benefit from extracorporeal CPR.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 130 (estimated) |
| Sponsor | Central China Fuwai Hospital of Zhengzhou University Academic / other |
| Locations | 1 site (Zhengzhou, Henan) |
| Status | Recruiting |
| Started | September 1, 2025 |
| Main results expected | December 30, 2026 |
| Study ends | December 30, 2026 |
| Registry record updated | March 23, 2026 |
| Trial ID | NCT07113769 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults (typically 18–70 years) with witnessed refractory cardiac arrest who receive immediate bystander CPR, have potentially reversible causes, and meet local ECPR eligibility are the ideal candidates.
✕Probably not a fit
Patients with un-witnessed arrests, long delays to CPR, active infectious or hematologic disease, or non-reversible causes of arrest are unlikely to gain benefit from the markers targeted in this project.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This is an observational study collecting plasma proteomic and metabolomic data plus detailed platelet ultrastructure from adults with refractory cardiac arrest treated with extracorporeal cardiopulmonary resuscitation (ECPR). Samples and platelet imaging will be obtained before and after ECPR to look for reproducible molecular and morphological markers. The goal is to find markers that predict which patients with reversible causes of arrest are most likely to benefit from ECPR. The work is being conducted at Central China Fuwai Hospital with regional hospital collaborators.
Why it matters
Potential benefit: If successful, clinicians could use blood- and platelet-based markers to better select cardiac arrest patients for ECPR, improving outcomes and avoiding futile interventions.
How similar studies have gone: Some prior work has explored biomarkers in ECMO and cardiac arrest, but reliable proteomic/metabolomic or platelet-structure predictors for selecting ECPR candidates remain largely unproven and this approach is relatively novel.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: 1. Age between 18 and 70 years old (the age limit can be relaxed if the patient has good organ function and a good neurological prognosis after evaluation). 2. The cardiac arrest is witnessed, and bystanders perform traditional cardiopulmonary resuscitation (CPR), and the time interval from the occurrence of cardiac arrest to the start of traditional CPR is no more than 5 minutes. 3. The causes of cardiac arrest are reversible, such as cardiogenic, pulmonary embolism, severe hypothermia, drug poisoning, trauma, acute respiratory distress syndrome, etc. 4. After 20 minutes of traditional CPR, there is no restoration of spontaneous circulation or hemodynamic instability, or the restoration of spontaneous circulation occurs, but the spontaneous heart rhythm cannot be maintained. 5. The informed consent has been signed. Exclusion Criteria: 1. Infectious diseases, such as hepatitis B, hepatitis C, AIDS, syphilis, etc. 2. Hematological diseases, such as hematological malignancies, aplastic anemia, idiopathic thrombocytopenic purpura (ITP), etc. 3. Malignant tumors in other systems except the hematological system. 4. Patients who have received massive plasma or platelet transfusions during hospitalization or recently.
Where it's running
-
Fuwai Central China Cardiovascular Hospital
Zhengzhou, Henan, China Recruiting
Study contacts
- Study coordinator: Jianchao Li
- Email: 381226651@qq.com
- Phone: +86 185 3998 9191
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Heartsight helps caregivers of kids after cardiac arrest manage uncertainty and fear
This pilot trial tests if the Heartsight information program is acceptable and helpful for caregivers of children who recently had a cardiac arrest.
-
Brain blood flow and brain regulation in critically ill kids
This study tests how blood flow in the brain behaves in critically ill children using a noninvasive ultrasound (TCD) to see if brain autoregulation patterns relate to outcomes.
-
Cardiopulmonary resuscitation with balloon occlusion of the descending aorta for hospitalized patients
This trial will test whether adding a balloon occlusion of the descending aorta (REBOA) to standard ACLS helps people having an in-hospital cardiac arrest regain and keep a pulse.
-
Digital serious game to improve critical care nurses' targeted temperature management skills and situational awareness.
We will test whether adding a digital serious game to regular lectures helps adult ICU nurses learn targeted temperature management and improve situational awareness.
-
Targeted Temperature Management at 33°C for in-hospital cardiac arrest
This trial tests whether cooling patients who remain unconscious after a resuscitated in-hospital cardiac arrest to 33°C improves survival with good brain function compared to keeping a normal, controlled temperature.
-
Co-designed pain and sedation protocol for adults on ECMO
This project will test a co-designed pain and sedation plan to see if it's acceptable for adults receiving ECMO and similar ventilated ICU patients.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.